Regeneron Pharma (REGN) PT Lowered to $730 at BMO Capital Following LAG-3 Miss
Tweet Send to a Friend
(Updated - May 18, 2026 9:39 AM EDT)
BMO Capital analyst Evan David Seigerman lowered the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst Evan David Seigerman lowered the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
